nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Uveitis—Azathioprine—systemic scleroderma	0.0344	0.0344	CcSEcCtD
Latanoprost—Lacrimation increased—Pentoxifylline—systemic scleroderma	0.0197	0.0197	CcSEcCtD
Latanoprost—Stinging—Mometasone—systemic scleroderma	0.0193	0.0193	CcSEcCtD
Latanoprost—Blepharitis—Mycophenolate mofetil—systemic scleroderma	0.0139	0.0139	CcSEcCtD
Latanoprost—Keratitis—Mycophenolate mofetil—systemic scleroderma	0.0132	0.0132	CcSEcCtD
Latanoprost—Dry eye—Captopril—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Latanoprost—Inflammation—Leflunomide—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Latanoprost—Angina pectoris—Pentoxifylline—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Latanoprost—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00998	0.00998	CcSEcCtD
Latanoprost—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.00987	0.00987	CcSEcCtD
Latanoprost—Asthma—Mometasone—systemic scleroderma	0.00983	0.00983	CcSEcCtD
Latanoprost—Bronchitis—Mometasone—systemic scleroderma	0.00945	0.00945	CcSEcCtD
Latanoprost—Eczema—Leflunomide—systemic scleroderma	0.00916	0.00916	CcSEcCtD
Latanoprost—Photophobia—Lisinopril—systemic scleroderma	0.00915	0.00915	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.00914	0.00914	CcSEcCtD
Latanoprost—Embolism—Prednisone—systemic scleroderma	0.00902	0.00902	CcSEcCtD
Latanoprost—Urinary tract infection—Mometasone—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Latanoprost—Conjunctivitis—Mometasone—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Latanoprost—Angina pectoris—Captopril—systemic scleroderma	0.00841	0.00841	CcSEcCtD
Latanoprost—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.0081	0.0081	CcSEcCtD
Latanoprost—Photophobia—Mycophenolate mofetil—systemic scleroderma	0.00802	0.00802	CcSEcCtD
Latanoprost—Erythema—Pentoxifylline—systemic scleroderma	0.00794	0.00794	CcSEcCtD
Latanoprost—Eczema—Lisinopril—systemic scleroderma	0.00787	0.00787	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00785	0.00785	CcSEcCtD
Latanoprost—Dermatitis atopic—Prednisone—systemic scleroderma	0.00782	0.00782	CcSEcCtD
Latanoprost—Back pain—Pentoxifylline—systemic scleroderma	0.00768	0.00768	CcSEcCtD
Latanoprost—Embolism—Methotrexate—systemic scleroderma	0.00754	0.00754	CcSEcCtD
Latanoprost—Vision blurred—Pentoxifylline—systemic scleroderma	0.00748	0.00748	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00741	0.00741	CcSEcCtD
Latanoprost—Asthma—Leflunomide—systemic scleroderma	0.00712	0.00712	CcSEcCtD
Latanoprost—Mediastinal disorder—Mometasone—systemic scleroderma	0.00709	0.00709	CcSEcCtD
Latanoprost—Diplopia—Lisinopril—systemic scleroderma	0.00707	0.00707	CcSEcCtD
Latanoprost—Angina pectoris—Leflunomide—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Latanoprost—Eye pain—Mycophenolate mofetil—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Latanoprost—Bronchitis—Leflunomide—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Latanoprost—Asthma—Mycophenolic acid—systemic scleroderma	0.00679	0.00679	CcSEcCtD
Latanoprost—Chest pain—Pentoxifylline—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Latanoprost—Discomfort—Pentoxifylline—systemic scleroderma	0.00668	0.00668	CcSEcCtD
Latanoprost—Back pain—Mometasone—systemic scleroderma	0.00663	0.00663	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Latanoprost—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Latanoprost—Bronchitis—Mycophenolic acid—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Latanoprost—Oedema—Pentoxifylline—systemic scleroderma	0.00648	0.00648	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00637	0.00637	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Latanoprost—Skin disorder—Pentoxifylline—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Latanoprost—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.0062	0.0062	CcSEcCtD
Latanoprost—Conjunctivitis—Leflunomide—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Latanoprost—Urinary tract infection—Leflunomide—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Latanoprost—Asthma—Lisinopril—systemic scleroderma	0.00611	0.00611	CcSEcCtD
Latanoprost—Angina pectoris—Lisinopril—systemic scleroderma	0.00596	0.00596	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Latanoprost—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Latanoprost—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Latanoprost—Bronchitis—Lisinopril—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Latanoprost—Arthralgia—Mometasone—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Latanoprost—Chest pain—Mometasone—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Latanoprost—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00568	0.00568	CcSEcCtD
Latanoprost—Vision blurred—Captopril—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Latanoprost—Connective tissue disorder—Leflunomide—systemic scleroderma	0.0056	0.0056	CcSEcCtD
Latanoprost—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00544	0.00544	CcSEcCtD
Latanoprost—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Latanoprost—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Latanoprost—Urinary tract infection—Lisinopril—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Latanoprost—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Latanoprost—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00515	0.00515	CcSEcCtD
Latanoprost—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Latanoprost—Arthralgia—Captopril—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Latanoprost—Chest pain—Captopril—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00509	0.00509	CcSEcCtD
Latanoprost—Discomfort—Captopril—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Latanoprost—Inflammation—Methotrexate—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Latanoprost—Dyspnoea—Mometasone—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Latanoprost—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Latanoprost—Back pain—Leflunomide—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Latanoprost—Pain—Mometasone—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Latanoprost—Vision blurred—Leflunomide—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Latanoprost—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Latanoprost—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Latanoprost—Pruritus—Pentoxifylline—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Latanoprost—Back pain—Mycophenolic acid—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Latanoprost—Arthralgia—Azathioprine—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Latanoprost—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Latanoprost—Discomfort—Azathioprine—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Latanoprost—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Latanoprost—Dyspnoea—Captopril—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Latanoprost—Dizziness—Pentoxifylline—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Latanoprost—Erythema—Lisinopril—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Latanoprost—Arthralgia—Leflunomide—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Latanoprost—Chest pain—Leflunomide—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Latanoprost—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Latanoprost—Discomfort—Leflunomide—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Latanoprost—Skin disorder—Azathioprine—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Latanoprost—Back pain—Lisinopril—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Latanoprost—Rash—Pentoxifylline—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Latanoprost—Dermatitis—Pentoxifylline—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Latanoprost—Headache—Pentoxifylline—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Latanoprost—Chest pain—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Latanoprost—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Latanoprost—Vision blurred—Lisinopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.004	0.004	CcSEcCtD
Latanoprost—Discomfort—Mycophenolic acid—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Latanoprost—Nervous system disorder—Leflunomide—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Latanoprost—Pruritus—Mometasone—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Latanoprost—Skin disorder—Leflunomide—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Latanoprost—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Latanoprost—Oedema—Mycophenolic acid—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Latanoprost—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Latanoprost—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Latanoprost—Arthralgia—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Latanoprost—Chest pain—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Latanoprost—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Latanoprost—Dyspnoea—Leflunomide—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Latanoprost—Discomfort—Lisinopril—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Latanoprost—Rash—Mometasone—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Latanoprost—Dermatitis—Mometasone—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Latanoprost—Headache—Mometasone—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Latanoprost—Oedema—Lisinopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Latanoprost—Pruritus—Captopril—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Latanoprost—Pain—Leflunomide—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Latanoprost—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Latanoprost—Skin disorder—Lisinopril—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Latanoprost—Pain—Mycophenolic acid—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Latanoprost—Dizziness—Captopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Latanoprost—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Latanoprost—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Latanoprost—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Latanoprost—Dyspnoea—Lisinopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Latanoprost—Rash—Captopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Latanoprost—Dermatitis—Captopril—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Latanoprost—Headache—Captopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Latanoprost—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Latanoprost—Asthma—Methotrexate—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Latanoprost—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Latanoprost—Pain—Lisinopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Latanoprost—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Latanoprost—Pruritus—Leflunomide—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Latanoprost—Connective tissue disorder—Prednisone—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Latanoprost—Dizziness—Azathioprine—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Latanoprost—Pruritus—Mycophenolic acid—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Latanoprost—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Latanoprost—Rash—Azathioprine—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Latanoprost—Dermatitis—Azathioprine—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Latanoprost—Headache—Azathioprine—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Latanoprost—Dizziness—Leflunomide—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Latanoprost—Pain—Mycophenolate mofetil—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Latanoprost—Dizziness—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Latanoprost—Rash—Leflunomide—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Latanoprost—Dermatitis—Leflunomide—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Latanoprost—Headache—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Latanoprost—Erythema—Prednisone—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Latanoprost—Pruritus—Lisinopril—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Latanoprost—Rash—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Latanoprost—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Latanoprost—Headache—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Latanoprost—Vision blurred—Prednisone—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Latanoprost—Dizziness—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Latanoprost—Rash—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Latanoprost—Dermatitis—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Latanoprost—Headache—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Latanoprost—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Latanoprost—Arthralgia—Prednisone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Latanoprost—Discomfort—Prednisone—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Latanoprost—Erythema—Methotrexate—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Latanoprost—Oedema—Prednisone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Latanoprost—Back pain—Methotrexate—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Latanoprost—Nervous system disorder—Prednisone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Latanoprost—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Latanoprost—Skin disorder—Prednisone—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Latanoprost—Rash—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Latanoprost—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Latanoprost—Headache—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Latanoprost—Chest pain—Methotrexate—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Latanoprost—Nervous system disorder—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Latanoprost—Skin disorder—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Latanoprost—Dyspnoea—Methotrexate—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Latanoprost—Pain—Methotrexate—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Latanoprost—Pruritus—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Latanoprost—Dizziness—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Latanoprost—Rash—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Latanoprost—Dermatitis—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Latanoprost—Headache—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Latanoprost—Pruritus—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Latanoprost—Dizziness—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Latanoprost—Rash—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Latanoprost—Headache—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
